Achieving complete remission after sequential treatment with docetaxel‑cabazitaxel enzalutamide in a patient with metastatic castration‑resistant prostate cancer


MUDr. Robert Novák1; MUDr. Jana Katolická, Ph.D.1; MUDr. Jiří Vašina2

1 Onkologicko-chirurgické oddělení, FN u sv. Anny, Brno

2 Oddělení nukleární medicíny, Masarykův onkologický ústav, Brno



In our case report, we present a case of a patient initially with locally-regionally advanced prostate cancer. The complete remission was achieved after sequential treatment of docetaxel-cabazitaxel-enzalutamide, with maintaining good quality of life.


Key words

prostate cancer, docetaxel, cabazitaxel, enzalutamide, quality of life



The full article is only available to subscribers

Become a regular subscriber to our Oncological Review...